France's Cellectis To Acquire Cellartis To Produce A Leader In Stem Cell Technologies
This article was originally published in The Pink Sheet Daily
Executive Summary
The genome engineering company, Cellectis, is to acquire the Swedish human embryonic stem cell firm Cellartis in a €30 million deal expected to complete at the end of October.